NET LOSS PER SHARE

9 Months Ended

Sep. 28, 2025

During the thirteen and thirty-nine weeks ended September 28, 2025 and September 29, 2024, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, the undistributed earnings were allocated on a proportionate basis and the resulting net loss per share attributable to common stockholders were, therefore, the same for both Class A and Class B common stock on an individual or combined basis.

The following table sets forth the computation of net loss per common share:


	Thirteen weeks ended				Thirty-nine weeks ended
	September 28, 2025		September 29, 2024		September 28, 2025		September 29, 2024
(dollar amounts in thousands)
Numerator:
Net loss	$	(36,146)	$	(20,816)	$	(84,343)	$	(61,343)
Denominator:
Weighted-average common shares outstanding—basic and diluted	118,282,536		114,752,307		117,804,955		113,743,453
Earnings per share—basic and diluted	$	(0.31)	$	(0.18)	$	(0.72)	$	(0.54)

The Company’s potentially dilutive securities, which include time-based vesting restricted stock units, performance stock units, contingently issuable stock and options to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive. Therefore, the

weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	Thirteen weeks ended		Thirty-nine weeks ended
	September 28, 2025	September 29, 2024	September 28, 2025	September 29, 2024
Options to purchase common stock	14,035,191	13,607,548	14,035,191	13,607,548

Time-based vesting restricted stock units	563,811	1,016,297	563,811	1,016,297
Performance stock units	4,500,000	5,400,000	4,500,000	5,400,000
Contingently issuable stock	250,000	506,243	250,000	506,243
Total common stock equivalents	19,349,002	20,530,088	19,349,002	20,530,088